Metis Global Partners LLC Purchases 990 Shares of Teleflex Incorporated (NYSE:TFX)

Metis Global Partners LLC boosted its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 44.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,200 shares of the medical technology company’s stock after purchasing an additional 990 shares during the quarter. Metis Global Partners LLC’s holdings in Teleflex were worth $798,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. increased its position in shares of Teleflex by 1.7% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 7,949 shares of the medical technology company’s stock valued at $1,561,000 after buying an additional 136 shares in the last quarter. Mackenzie Financial Corp increased its holdings in shares of Teleflex by 227.3% in the third quarter. Mackenzie Financial Corp now owns 16,692 shares of the medical technology company’s stock worth $3,231,000 after acquiring an additional 11,592 shares in the last quarter. IFM Investors Pty Ltd raised its position in shares of Teleflex by 5.0% during the third quarter. IFM Investors Pty Ltd now owns 8,541 shares of the medical technology company’s stock worth $1,678,000 after purchasing an additional 403 shares during the period. Advisor Partners II LLC raised its position in shares of Teleflex by 4.8% during the third quarter. Advisor Partners II LLC now owns 1,867 shares of the medical technology company’s stock worth $367,000 after purchasing an additional 86 shares during the period. Finally, ING Groep NV bought a new position in shares of Teleflex during the 3rd quarter valued at about $39,000. Institutional investors own 95.62% of the company’s stock.

Insider Transactions at Teleflex

In related news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the sale, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.43% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. JMP Securities reissued a “market outperform” rating and set a $285.00 target price on shares of Teleflex in a research note on Friday, February 23rd. Truist Financial dropped their price objective on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a report on Friday, May 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Royal Bank of Canada lowered their target price on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Finally, StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average target price of $261.75.

Read Our Latest Research Report on TFX

Teleflex Price Performance

NYSE:TFX opened at $204.63 on Friday. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $262.97. The company has a market cap of $9.64 billion, a P/E ratio of 32.85, a P/E/G ratio of 1.95 and a beta of 1.13. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The stock’s 50-day simple moving average is $215.39 and its 200 day simple moving average is $226.44.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, topping the consensus estimate of $3.07 by $0.14. The firm had revenue of $737.80 million for the quarter, compared to analyst estimates of $726.85 million. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The business’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.09 EPS. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.72 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Tuesday, May 14th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

See Also

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.